Nestle Recalls More Guigoz Baby Formula As France Tightens Toxin Level
Cereulide, which can cause nausea and vomiting, has been detected in ingredients from a factory in China supplying many infant formula makers, including Nestle, Danone and Lactalis. The findings have triggered recalls in dozens of countries and raised concerns among parents.
Recommended For You"As methods for analysing cereulide have evolved, we are voluntarily recalling a batch of Guigoz infant formula in addition to the batches already recalled," Nestle said on its recall alert.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
Analysts had said further recalls were unlikelyFrance reduced its safety limit for cereulide on Saturday, aiming to strengthen protections after recalls widened to include other companies such as Vitagermine. The new threshold followed a meeting with the EU's food safety authority EFSA, which issued similar advice on Monday.
Analysts at Barclays and Jefferies had said on Monday they did not expect Nestle and Danone to face additional recalls as a result of the updated limit.
Nestle had already recalled some Guigoz batches, among other brands, in France in January and December.
French investigators are looking into whether there is a link between the death of two infants and recalled Guigoz infant formula products, local prosecutors said.
The French health ministry and the company said there was no evidence of such a connection at this stage. Results are expected in the coming days.
ALSO READ- Nestle recalls infant formula batches across Europe on food safety concerns 4 GCC countries recall batches of Nestle's infant formula Nestle recalls infant formulas: Symptoms parents should watch out for
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment